Oncology

0071
(NQF #0387)

Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer
National Quality Strategy Domain: Effective Clinical Care

Was patient prescribed tamoxifen or aromatase inhibitor (AI)?
.

Tamoxifen or aromatase inhibitor (AI) prescribed.
(4179F) (Performance Met)
4179F

Documentation of medical reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient’s disease has progressed to metastatic, patient is receiving a gonadotropin-releasing hormone analogue, patient has received oophorectomy, patient is receiving radiation or chemotherapy, patient’s diagnosis date was > 5 years from reporting date, patient’s diagnosis date is within 120 days of the end of the 12 month reporting period, other medical reasons).
(4179F:1P) (Medical Performance Exclusion)
4179F:1P

Documentation of patient reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient refusal, other patient reasons).
(4179F:2P) (Patient Performance Exclusion)
4179F:2P

Documentation of system reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient is currently enrolled in a clinical trial, other system reasons).
(4179F:3P) (Patient Performance Exclusion)
4179F:3P

Tamoxifen or aromatase inhibitor not prescribed, reason not otherwise specified.
(4179F:8P) (Performance Not Met)
4179F:8P

X
y
y

0072
(NQF #0385)

Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients
National Quality Strategy Domain: Effective Clinical Care

Was patient referred or prescribed adjuvant chemotherapy, or previosly received chemotherapy?
According to current NCCN guidelines, the following therapies are recommended: 5-FU/LV/oxaliplatin (FOLFOX) or capecitabine/oxaliplatin (CapeOx) (both category 1 and preferred); bolus 5-FU/LV/oxaliplatin (FLOX) (category 1); or single-agent capecitabine or 5-FU/LV in patients felt to be inappropriate for oxaliplatin therapy (NCCN). See clinical recommendation statement for cases where leucovorin is not available.

Adjuvant chemotherapy referred, prescribed or previously received for AJCC Stage III, colon cancer.
(G8927) (Performance Met)
G8927

Adjuvant chemotherapy not prescribed or previously received for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient’s diagnosis date is within 120 days of the end of the 12 month reporting period, patient’s cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons).
(G8928) (Other Performance Exclusions)
G8928

Adjuvant chemotherapy not prescribed or previously received, reason not given.
(G8929) (Performance Not Met)
G8929

X
y
y

0110
(NQF 0041)

Preventive Care and Screening: Influenza Immunization
National Quality Strategy Domain: Community/Population Health

Did patient receive an influenza immunization for this flu season OR report a previous receipt of an influenza immunization?
Patients 6 months and older seen for a visit between October 1 and March 31 OR who reported previous receipt of an influenze immunization.

Influenza immunization administered or previously received.
(G8482) (Performance Met)
G8482

Influenza immunization not administered, reason documented. (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons).
(G8483) (Performance Met)
G8483

Influenza immunization was not administered, reason not given.
(G8484) (Performance Not Met)
G8484

X
y
y

0130
(NQF #0419)

Documentation of Current Medications in the Medical Record
National Quality Strategy Domain: Patient Safety

Are current medications documented in the patient's medical record?
Eligible professional attests to documenting in the medical record they obtained, updated, or reviewed the patient’s current medications.

Current medications documented.
(G8427) (Performance Met)
G8427

Eligible professional attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible professional.
(G8430) (Other Performance Exclusion)
G8430

Current list of medications not documented as obtained, updated, or reviewed by the eligible professional, reason not given.
(G8428) (Performance Not Met)
G8428

X
y
y

0143
(NQF #0384)

Oncology: Medical and Radiation – Pain Intensity Quantified
National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes

Was patient's pain intensity quantified?
Pain intensity should be quantified using a standard instrument, such as a 0-10 numerical rating scale, visual analog scale, a categorical scale, or the pictorial scale.

Pain severity quantified; pain present.
(1125F) (Performance Met)
1125F

Pain severity quantified; no pain present.
(1126F) (Performance Met)
1126F

Pain severity not documented, reason not otherwise specified.
(1125F:8P) (Performance Not Met)
1125F:8P

X
y
y

0144
(NQF #0383)

Oncology: Medical and Radiation – Plan of Care for Pain
National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes

Was plan of care to address pain documented?
.

Plan of care to address pain documented.
(0521F) (Performance Met)
0521F

Plan of care for pain not documented, reason not otherwise specified.
(0521F:8P)(Performance Not Met)
0521F:8P

X
y
y

0226
(NQF #0028)

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
National Quality Strategy Domain: Community / Population Health

Was patient screened for tobacco use within 24 months AND given tobacco cessation interventionn if identified as a tobacco user?
Tobacco use includes use of any type of tobacco; tobacco cessation intervention includes brief counseling (3 minutes or less), and/or pharmacotherapy.

Patient screened for tobacco use AND received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user.
(4004F) (Performance Met)
4004F

Current tobacco non-user.
(1036F) (Performance Met)
1036F

Documentation of medical reason(s) for not screening for tobacco use (eg, limited life expectancy, other medical reasons).
(4004F:1P) (Medical Performance Exclusion)
4004F:1P

Tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified.
(4004F:8P) (Performance Not Met)
4004F:8P

X
y
n
